bioRxiv Science⌕ Search

Biology subjects

Tan, S.-Y.

Publications and source records attributed to Tan, S.-Y..

6 recordsLinked to original sources

Cross-phosphorylation of RR06 by the non-cognate kinase VncS activates the adhesin CbpA in Streptococcus pneumoniae.

Streptococcus pneumoniae establishes asymptomatic nasopharyngeal colonization before progressing to invasive disease, a process that requires precise spatiotemporal regulation of surface adhesins. Using a barcoded capsule-switch mutant library and randomly barcoded transposon sequencing (RB-TnSeq), we identified determinants of pneumococcal adhesion to the human alveolar epithelial cell line A549. The capsule masked surface adhesins and reduced binding across all 84 serotypes tested. The transposon screen revealed that overexpression of vncS, the sensor kinase of the two-component system TCS10, markedly increased adhesion, whereas disruption of its cognate response regulator VncR had no detectable effect. Transcriptomic profiling and genetic epistasis established that the adhesin CbpA, known to be regulated by TCS06, is the effector of VncS-driven adhesion. VncS activated cbpA expression through the non-cognate response regulator RR06, independently of VncR. Phos-tag gel analysis demonstrated that VncS cross-phosphorylates RR06 in vivo, and that the cognate kinase HK06 limits this crosstalk by acting primarily as a phosphatase toward RR06. Substitution of the conserved S241 residue of HK06 increased RR06[~]P levels and upregulated cbpA. By contrast, deleting vncS and hk06 reduced RR06 phosphorylation to nearly undetectable levels. These findings resolve a long-standing mechanistic controversy regarding RR06 activation and uncover a potentially unrecognized role for VncS in regulating pneumococcal host cell adhesion. SIGNIFICANCEStreptococcus pneumoniae is a leading cause of pneumonia, and its ability to colonize the human airway depends on surface adhesins. Several two-component signaling systems are known to regulate adhesin expression, but how their outputs are integrated remains incompletely understood. Here, we identify determinants of pneumococcal adhesion to human alveolar epithelial cells at both the serotype and genotype levels. We show that the histidine kinase VncS cross-phosphorylates the non-cognate response regulator RR06 to activate the adhesin CbpA, whereas the cognate kinase HK06 primarily acts as a phosphatase to restrain this crosstalk. These findings resolve a long-standing controversy regarding RR06 activation and reveal a regulatory node that links two signaling systems to a single virulence output.

microbiology↗

Plasma Ficolins Enable Liver Macrophages to Capture Blood-Borne Bacteria by Recognizing Capsular Polysaccharides

Ficolins are evolutionarily conserved glycan-binding lectins in plasma or on cell membranes of immune cells, yet their physiological functions remain to be defined. Here we demonstrate that plasma ficolins drives the capture of diverse encapsulated bacteria in the blood circulation by the liver resident macrophages (Kupffer cells). Ficolin-activated immunity in the liver sinusoids provides swift and sterilizing immunity in mice. Mice lacking ficolin-A (the only plasma ficolin) became hypersusceptible to the blood infections of the ficolin-A-recognizable bacterial serotypes. Mechanistically, plasma ficolins activate complement C3 on bacterial surfaces by pattern recognition of acetylated monosaccharides on polysaccharide capsules, and thereby deliver the opsonized bacteria to C3 receptors on Kupffer cells for phagocytic elimination. These findings reveal that plasma ficolins serve as pattern-recognition receptors that are essential for maintaining the bloodstream sterile.

microbiology↗

A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line tuberculosis regimen

Drug-resistant tuberculosis (DR-TB) results from infection by Mycobacterium tuberculosis strains resistant to at least rifampin or isoniazid. To improve the treatment outcome in DR-TB, therapeutic vaccines are considered an ideal choice as they can enhance pathogen clearance and minimize disease sequelae. To date, there is no therapeutic vaccine reported to be effective when combined with a chemotherapy regimen against DR-TB. The only available TB vaccine, the M. bovis BCG (BCG) is susceptible to several anti-TB drugs hence not a perfect option for therapeutic vaccination. Herein, we developed a recombinant BCG (RdrBCG) overexpressing Ag85B and Rv2628 with resistance to selected anti-TB drugs. When administered three times adjunct to a second-line anti-TB regimen in a classical murine model of DR-TB, the RdrBCG lowered lung M. tuberculosis colony-forming units by 1 log10. Furthermore, vaccination with the RdrBCG adjunct to TB chemotherapy minimized lung tissue pathology in mice. Most importantly, the RdrBCG maintained the exogenously inserted genes and showed almost the same virulence as its parent BCG Tice strain in severe combined immune-deficient mice. All these suggested that the RdrBCG was stable, safe and effective. Hence, the "recombinant" plus "drug-resistant" BCG strategy could be a useful concept for developing therapeutic vaccines against DR-TB.

microbiology↗

Data-driven analysis of COVID-19 reveals specific severity patterns distinct from the temporal immune response

Key immune signatures of SARS-CoV-2 infection may associate with either adverse immune reactions (severity) or simply an ongoing anti-viral response (temporality); how immune signatures contribute to severe manifestations and/or temporal progression of disease and whether longer disease duration correlates with severity remain unknown. Patient blood was comprehensively immunophenotyped via mass cytometry and multiplex cytokine arrays, leading to the identification of 327 basic subsets that were further stratified into more than 5000 immunotypes and correlated with 28 plasma cytokines. Low-density neutrophil abundance was closely correlated with hepatocyte growth factor levels, which in turn correlated with disease severity. Deep analysis also revealed additional players, namely conventional type 2 dendritic cells, natural killer T cells, plasmablasts and CD16+ monocytes, that can influence COVID-19 severity independent of temporal progression. Herein, we provide interactive network analysis and data visualization tools to facilitate data mining and hypothesis generation for elucidating COVID-19 pathogenesis.

immunology↗

Potent neutralizing antibodies in the sera of convalescent COVID-19 patients are directed against conserved linear epitopes on the SARS-CoV-2 spike protein

The ongoing SARS-CoV-2 pandemic demands rapid identification of immunogenic targets for the design of efficient vaccines and serological detection tools. In this report, using pools of overlapping linear peptides and functional assays, we present two immunodominant regions on the spike glycoprotein that were highly recognized by neutralizing antibodies in the sera of COVID-19 convalescent patients. One is highly specific to SARS-CoV-2, and the other is a potential pan-coronavirus target.

immunology↗

Demonstration of different entity of appendicitis and related causes of disease through study of cluster/outbreak: Systematic Review and Meta Analysis.

ObjectiveTo demonstrate different entities of appendicitis and causal association between microbiota and different types of appendicitis through studying cluster/outbreak, and providing guidance to find new cluster/outbreak of appendicitis and the epidemiological evidences of infectious etiology of appendicitis.\n\nData SourcesPubMed, Embase, CNKI, WanFang, VIP, CBM from their establishment to Jan, 2019, and the references lists from retrieved reports.\n\nStudy EligibilityReports on cluster/outbreak of appendicitis and reports of case series occurring in cluster/outbreak worldwide according to CDCs definition of cluster/outbreak.\n\nData Extraction and SynthesisTwo researchers independently assessed report quality and extracted data according to Moose. We used random effect model for meta-analysis by Meta-Analyst {beta}3.13 software. Study-level assessment was conducted according to investigation methods introduced by Reingold and outcome-level assessment by GRADE system. We selected outcome measures before data collection began.\n\nResultsWe included 10 clusters/outbreaks of appendicitis from China and USA with total 626 patients. We demonstrated two entities, type 1 appendicitis (455 patients) and type 2 appendicitis (151patients). 20 patients left were unclassified type. For type 1 appendicitis, Natural history showed progression from a non-perforated appendicitis to perforated appendicitis as described traditionally. More than 88% of patients had elevated body temperature, WBC and neutrophil percentage. For type 2 appendicitis, natural history showed that only a few patients developed into phlegmonous appendicitis (6.9%,) or acute gangrenous appendicitis (1.4%) and no perforation or periappendicular abscess. More than 78% of patients had normal body temperature, WBC and NP. The patients time of type 1 appendicitis is shorter than that of type 2 appendicitis. Type 2 appendicitis had different histological features from type 1 appendicitis and was associated with fusobacteria. 9 of 10 cluster/outbreak occurred in group living unity such as school and camps, and many of them showed features of infectious diseases. The bodies of evidence were high quality in Meta analysis.\n\nConclusionCluster/outbreak of appendicitis is more often than expected worldwide and occurred in group living unity. Sporadic perforated appendicitis and non-perforated appendicitis may be not two different entities, but different stages of a same entity, which is inconsistent with modern classification of appendicitis. Type 2 appendicitis is a new entities. Studying cluster/outbreak is a new method in finding of new entity and causal association between microbiota and different types of appendicitis. Epidemiological evidence supported infectious etiology of appendicitis.

epidemiology↗